Chardan医疗保健收购 PHGE 深 沪
等待开盘 03-27 09:30:00 美东时间
4.74
-0.140
-2.87%
华盛通- 最 高8.10
- 今 开4.90
- 成交量 8.55万股
- 最 低 4.06
- 昨 收 4.88
- 总市值 14.12万
- 52周最高 8.50
- 市盈率 静 --
- 换手率 286.98%
- 52周最低 0.245
- 委 比 0.00%
- 总股本 2.98万
- 历史最高 11.90
- 量 比 0
- 振 幅 82.79%
- 历史最低 0.1301
- 每 手 1
- 风险率
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多HC Wainwright & Co. Downgrades BiomX to Neutral
HC Wainwright & Co. analyst Joseph Pantginis downgrades BiomX (AMEX:PHGE) from Buy to Neutral.
03-10 00:19
BiomX Appoints Michael Oster As CEO And David Rokach As CFO
Seasoned financial leaders join BiomX to support strategic execution and advancement of the companyDOVER, Del. and NESS ZIONA, Israel, March 9, 2026 /PRNewswire/ -- BiomX Inc. (NYSE:PHGE), a clinical-stage company
03-09 21:08
Market-Moving News for January 27th
JBLU: -7% | JetBlue Airways shares are trading lower after the company reported worse-than-expected Q4 EPS. PHGE: 165% | BiomX shares are trading higher after a 13D filing disclosed that Pyu Pyu Capital
01-27 20:19
BiomX Commences ~$3M Private Placement Of Series Y Convertible Preferred Stock
BiomX Inc. (NYSE American: PHGE) ("BiomX" or the "Company"), a clinical-stage company advancing novel natural and engineered phage therapies targeting specific pathogenic bacteria, today announced that it has entered
2025-12-29 21:05
12 Health Care Stocks Moving In Monday's Pre-Market Session
Gainers Adlai Nortye (NASDAQ:ANL) stock moved upwards by 44.5% to $2.37 during...
2025-12-29 20:05
Crude Oil Falls Over 1%; Structure Therapeutics Shares Jump
U.S. stocks traded lower midway through trading, with the Dow Jones index falli...
2025-12-09 01:46
US Stocks Mixed; Dow Falls Over 100 Points
U.S. stocks traded mixed this morning, with the Dow Jones index falling around ...
2025-12-08 23:04
Earnings Preview For BiomX
BiomX (AMEX:PHGE) is set to give its latest quarterly earnings report on Wednes...
2025-11-12 01:12
BiomX To Provide Latest Update On Phase 1b/2a Clinical Trial Data For BX004 At The North American Cystic Fibrosis Conference
BiomX Inc. (NYSE:PHGE) ("BiomX" or the "Company"), a clinical-stage company advancing novel natural and engineered phage therapies that target specific pathogenic bacteria, announces the Company will present further data
2024-09-18 20:19
BiomX To Present Phase 1b/2a Clinical Trial Data For BX004 At The ERS Congress 2024
BiomX Inc. (NYSE:PHGE) ("BiomX" or the "Company"), a clinical-stage company advancing novel natural and engineered phage therapies that target specific pathogenic bacteria, announces the Company will present data from BiomX's Phase 1b/2a study of BX004 for the treatment of cystic fibrosis patients w...
2024-09-03 20:23
